We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $579M
1-Year Est. Return 94.36%
This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+94.36%
3 Year Est. Return
+196.81%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$460M
AUM Growth
-$19.1M
Cap. Flow
-$3.4M
Cap. Flow %
-0.74%
Top 10 Hldgs %
71.83%
Holding
94
New
1
Increased
7
Reduced
8
Closed
8

Top Buys

1
MIST icon
Milestone Pharmaceuticals
MIST
+$4.28M
2
MRNS
Marinus Pharmaceuticals, Inc
MRNS
+$2.7M
3
CUE icon
Cue Biopharma
CUE
+$934K
4
OPTN
OptiNose
OPTN
+$666K
5
GPGI
GPGI Inc
GPGI
+$281K

Top Sells

1
TCDA
Tricida, Inc. Common Stock
TCDA
+$5.24M
2
LIN icon
Linde
LIN
+$3.76M
3
HCAR
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
+$1.49M
4
CELC icon
Celcuity
CELC
+$502K
5
BKTI icon
BK Technologies
BKTI
+$481K

Sector Composition

1 Consumer Discretionary 19.02%
2 Healthcare 16.99%
3 Industrials 15.02%
4 Financials 13.87%
5 Materials 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CORS.WS
51
DELISTED
Corsair Partnering Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CORS.WS
$137K 0.03%
416,666
– –
LILAK icon
52
Liberty Latin America Class C
LILAK
$1.5B
$126K 0.03%
18,174
– –
XOM icon
53
ExxonMobil
XOM
$605B
$119K 0.03%
1,075
– –
BNY
54
Bank of New York Mellon
BNY
$110B
$91K 0.02%
2,000
– –
ISPC icon
55
iSpecimen
ISPC
$3.18M
$90.5K 0.02%
82
– –
LGF.B
56
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$89.1K 0.02%
16,413
– –
CDNS icon
57
Cadence Design Systems
CDNS
$101B
$84.3K 0.02%
525
– –
ABBV icon
58
AbbVie
ABBV
$449B
$83.2K 0.02%
515
– –
CMPOW
59
DELISTED
CompoSecure Inc Warrant
CMPOW
$70K 0.02%
100,000
– –
AMD icon
60
Advanced Micro Devices
AMD
$817B
$59.2K 0.01%
913
– –
MO icon
61
Altria Group
MO
$122B
$54.9K 0.01%
1,200
– –
EQRXW
62
DELISTED
EQRx, Inc. Warrant
EQRXW
$53.6K 0.01%
200,000
– –
TER icon
63
Teradyne
TER
$50.5B
$52.4K 0.01%
600
– –
XFOR icon
64
X4 Pharmaceuticals
XFOR
$361M
$35.5K 0.01%
1,191
– –
LITE icon
65
Lumentum
LITE
$54.9B
$34.4K 0.01%
660
– –
T icon
66
AT&T
T
$153B
$30.4K 0.01%
1,650
– –
LILA icon
67
Liberty Latin America Class A
LILA
$1.51B
$30.2K 0.01%
5,913
– –
OPFI.WS icon
68
OppFi Inc Warrants
OPFI.WS
$25K 0.01%
250,000
– –
ARKG icon
69
ARK Genomic Revolution ETF
ARKG
$1.62B
$23.3K 0.01%
825
– –
ARKF icon
70
ARK Blockchain & Fintech Innovation ETF
ARKF
$761M
$17.1K ﹤0.01%
1,200
– –
AENTW icon
71
Alliance Entertainment Holding Corp Warrants
AENTW
$3.77M
$14.2K ﹤0.01%
200,000
– –
EQRX
72
DELISTED
EQRx, Inc. Common Stock
EQRX
$12.3K ﹤0.01%
5,000
– –
SVREW
73
SaverOne 2014 Ltd Warrant
SVREW
$12.1K ﹤0.01%
121,000
– –
ARKW icon
74
ARK Web x.0 ETF
ARKW
$1.67B
$11.6K ﹤0.01%
300
– –
FAZEW
75
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
$9.46K ﹤0.01%
75,000
– –
1 2
3
4

Similar funds

BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
LRIA
Leonard Rickey Investment Advisors Yakima, Washington $578M AUM 16.23% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
GCM
Gibraltar Capital Management Tulsa, Oklahoma $581M AUM 18.65% 1-Year Est. Return
KNW
Kesler Norman & Wride Ogden, Utah $581M AUM 17.6% 1-Year Est. Return

Bleichroeder LP's Q4 2022 Portfolio in Review

As of Q4 2022, Bleichroeder LP held 94 positions worth $460M, down 4% from $479M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Bleichroeder LP's Q4 2022 filing shows 1 new, 7 increased, 8 reduced and 8 closed positions. Its largest new stake was Xperi: 34 shares worth $293. The largest sale was Tricida, Inc. Common Stock, an estimated $5.24M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.

  • Bleichroeder LP's largest Q4 2022 buy was Xperi: 34 shares worth $293.
  • Bleichroeder LP added most to Milestone Pharmaceuticals in Q4 2022, an estimated $4.28M increase.
  • Bleichroeder LP's biggest Q4 2022 reduction was Linde, cutting an estimated $3.76M.
  • Bleichroeder LP fully exited Tricida, Inc. Common Stock in Q4 2022, selling an estimated $5.24M.
  • Bleichroeder LP's ten largest holdings make up 72% of its $460M portfolio in Q4 2022.
  • Bleichroeder LP opened 1 new position and closed 8 in Q4 2022.
  • Bleichroeder LP's portfolio value fell 4% quarter-over-quarter to $460M.

Based on Bleichroeder LP's 13F filing for Q4 2022, filed 14 Feb 2023.